Stories

This week’s research roundup features: Effect of urate-elevating inosine on early Parkinson disease progression: The SURE-PD3 randomized clinical trial.

Topic's Include: COVID-19 media only news briefing: What we know so far about post-COVID syndrome, Mayo Clinic Q&A podcast: The case for continuing COVID-19 precautions, and COVID queries: The speed of vaccine development.

As a referral specialist who works at a client site, Alonda Snelling-Faulk enjoys being part of the connection between patients and their test results. And as part of her job, she’s eager to learn all she can about the tests and what they mean for the people Mayo Clinic Laboratories serves.

This week's research roundup features: Therapeutic trials in adult FSGS: lessons learned and the road forward.

Dan O’Bryan didn’t think his dizziness and lightheadedness were anything to worry about. Nearly 100 miles away, the team at Mayo Clinic that was remotely monitoring Dan’s heart could see the truth.

Topic's Include: COVID-19 Queries: Can I develop a COVID infection from the vaccine? Mayo Clinic Q&A podcast: Breaking down COVID-19 vaccine booster approvals, and day of thanks for Mayo Clinic staff Nov. 26.

This week's research roundup features: Effect of probiotics on incident ventilator-associated pneumonia in critically Ill patients: A randomized clinical trial.

Topic's Include: COVID-19 Media Only News Briefing: Pfizer low-dose vaccine for kids, Mayo Clinic leads biorepository core for new nationwide research on long-term symptoms of COVID-19, and Mayo Clinic will begin offering booster vaccines.

This week's research roundup features: Performance assessment of DNA sequencing platforms in the ABRF Next-Generation Sequencing Study.

Topic's Include: COVID-19 media only news briefing: managing influenza during a pandemic, Mayo Clinic Q and A: COVID-19 vaccine boosters and third doses, and COVID Queries: Delta breakthrough infections.

Part two of the 50th Anniversary series highlights how Mayo Clinic Laboratories has remained focused on our core values through support of Mayo Clinic’s three shields – integrated clinical practice, research, and education.

As a regulatory affairs coordinator in Quality Management Services, it’s Corrisa Miliander’s job to report diseases to each state across the country as required by law — a crucial role that supports public health agencies as they work to monitor and control outbreaks of communicable diseases.

Personalized medicine represents unprecedented potential benefits for patients. LabConnect and Mayo Clinic BioPharma Diagnostics are working together to bring world-class laboratory testing and resources to industry partners conducting clinical research and trials.